ES553374A0 - Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes. - Google Patents
Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes.Info
- Publication number
- ES553374A0 ES553374A0 ES553374A ES553374A ES553374A0 ES 553374 A0 ES553374 A0 ES 553374A0 ES 553374 A ES553374 A ES 553374A ES 553374 A ES553374 A ES 553374A ES 553374 A0 ES553374 A0 ES 553374A0
- Authority
- ES
- Spain
- Prior art keywords
- production
- transformed
- hospedante
- procedure
- improve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 235000021120 animal protein Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858507833A GB8507833D0 (en) | 1985-03-26 | 1985-03-26 | Production of human somatomedin c |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES553374A0 true ES553374A0 (es) | 1987-05-16 |
| ES8705921A1 ES8705921A1 (es) | 1987-05-16 |
Family
ID=10576658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES553374A Expired ES8705921A1 (es) | 1985-03-26 | 1986-03-25 | Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0215110B1 (es) |
| JP (4) | JPH0691832B2 (es) |
| CN (1) | CN1034588C (es) |
| AT (1) | ATE87977T1 (es) |
| AU (1) | AU594950B2 (es) |
| CA (1) | CA1339305C (es) |
| DE (1) | DE3688225T2 (es) |
| DK (1) | DK175223B1 (es) |
| ES (1) | ES8705921A1 (es) |
| GB (1) | GB8507833D0 (es) |
| IL (1) | IL78278A0 (es) |
| NO (1) | NO302709B1 (es) |
| WO (1) | WO1986005810A1 (es) |
| ZA (1) | ZA862240B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0260149A1 (en) * | 1986-09-12 | 1988-03-16 | Howard Florey Institute Of Experimental Physiology And Medicine | Human prorelaxin for therapeutic use |
| GB8712540D0 (en) * | 1987-05-28 | 1987-07-01 | Ucb Sa | Expression of human proapolipoprotein a-i |
| US4876242A (en) * | 1987-09-21 | 1989-10-24 | Merck & Co., Inc. | Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
| AUPP807899A0 (en) | 1999-01-08 | 1999-02-04 | University Of Queensland, The | Codon utilization |
| JP6018719B1 (ja) * | 2016-03-15 | 2016-11-02 | Ｂｘ新生精機株式会社 | シャッター開閉機の巻上装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE95236T1 (de) * | 1983-04-25 | 1993-10-15 | Chiron Corp | Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren. |
| IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| SE8303626D0 (sv) * | 1983-06-23 | 1983-06-23 | Kabigen Ab | A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced |
| EP0151760A1 (en) * | 1984-01-06 | 1985-08-21 | Takeda Chemical Industries, Ltd. | Novel DNA and use thereof |
| US4758512A (en) * | 1984-03-06 | 1988-07-19 | President And Fellows Of Harvard College | Hosts and methods for producing recombinant products in high yields |
-
1985
- 1985-03-26 GB GB858507833A patent/GB8507833D0/en active Pending
-
1986
- 1986-03-21 CA CA000504757A patent/CA1339305C/en not_active Expired - Lifetime
- 1986-03-25 ES ES553374A patent/ES8705921A1/es not_active Expired
- 1986-03-25 ZA ZA862240A patent/ZA862240B/xx unknown
- 1986-03-25 WO PCT/US1986/000579 patent/WO1986005810A1/en active IP Right Grant
- 1986-03-25 JP JP61501992A patent/JPH0691832B2/ja not_active Expired - Lifetime
- 1986-03-25 AT AT86902217T patent/ATE87977T1/de not_active IP Right Cessation
- 1986-03-25 DE DE8686902217T patent/DE3688225T2/de not_active Expired - Lifetime
- 1986-03-25 AU AU56657/86A patent/AU594950B2/en not_active Expired
- 1986-03-25 EP EP86902217A patent/EP0215110B1/en not_active Expired - Lifetime
- 1986-03-26 IL IL78278A patent/IL78278A0/xx unknown
- 1986-03-26 CN CN86102889A patent/CN1034588C/zh not_active Expired - Lifetime
- 1986-11-25 NO NO864724A patent/NO302709B1/no unknown
- 1986-11-26 DK DK198605698A patent/DK175223B1/da not_active IP Right Cessation
-
1994
- 1994-05-09 JP JP6117443A patent/JP2602628B2/ja not_active Expired - Lifetime
- 1994-05-09 JP JP6117430A patent/JP2568383B2/ja not_active Expired - Lifetime
- 1994-05-09 JP JP6117435A patent/JPH07102152B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0215110A4 (en) | 1987-07-09 |
| GB8507833D0 (en) | 1985-05-01 |
| DE3688225T2 (de) | 1993-07-22 |
| DK175223B1 (da) | 2004-07-12 |
| NO864724L (no) | 1987-01-23 |
| NO302709B1 (no) | 1998-04-14 |
| JPS62502305A (ja) | 1987-09-10 |
| JPH07145200A (ja) | 1995-06-06 |
| JPH07102152B2 (ja) | 1995-11-08 |
| AU5665786A (en) | 1986-10-23 |
| ZA862240B (en) | 1986-11-26 |
| EP0215110B1 (en) | 1993-04-07 |
| ATE87977T1 (de) | 1993-04-15 |
| DE3688225D1 (de) | 1993-05-13 |
| JP2602628B2 (ja) | 1997-04-23 |
| CN86102889A (zh) | 1986-11-26 |
| WO1986005810A1 (en) | 1986-10-09 |
| DK569886A (da) | 1986-11-26 |
| DK569886D0 (da) | 1986-11-26 |
| EP0215110A1 (en) | 1987-03-25 |
| ES8705921A1 (es) | 1987-05-16 |
| JP2568383B2 (ja) | 1997-01-08 |
| AU594950B2 (en) | 1990-03-22 |
| JPH07143885A (ja) | 1995-06-06 |
| CA1339305C (en) | 1997-08-19 |
| JPH07143896A (ja) | 1995-06-06 |
| IL78278A0 (en) | 1986-07-31 |
| JPH0691832B2 (ja) | 1994-11-16 |
| CN1034588C (zh) | 1997-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO885326D0 (no) | Human vevfaktor-beslektede dna-segmenter, polypeptider og antistoffer. | |
| ES2059354T3 (es) | Un metodo para producir un polipeptido. | |
| DE3586189D1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
| DE3880739D1 (de) | Expression von menschlichem proapolipoprotein a-1. | |
| DE3382837D1 (de) | Herstellung von funktionellen, menschlichen Urokinaseproteinen | |
| HK14991A (en) | Recombinant dna molecules and their method of production | |
| FI920923A0 (fi) | Fusionsproteiner, deras framstaellning samt anvaendning. | |
| DK215287D0 (da) | Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette | |
| MX164375B (es) | Procedimiento biotecnologico para preparar moleculas adn recombinantes y polipeptidos de tipo de hormona de crecimiento en cerdos | |
| IL69469A (en) | Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors | |
| MX9203519A (es) | Metodo de recombinacion para la produccion de inhibidores de proteasa de serina y secuencias de adn utiles para los mismos. | |
| DK611386A (da) | Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden | |
| ES553374A0 (es) | Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes. | |
| DE3584029D1 (de) | Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden. | |
| DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
| ZA874677B (en) | Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| DE69932644D1 (de) | Menschliches Protein mit in vitro antiproliferativer Aktivität. | |
| FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi | |
| DK1241184T3 (da) | Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1A | Transfer granted |
Owner name: BIOGEN, INC. |
|
| FD1A | Patent lapsed |
Effective date: 20070321 |